Inventor
SHEN WENYAN
US49 patents
⚠️ This page may combine multiple inventors who share the name “SHEN WENYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
20 patentsUS8030457B2Oct 4, 2011
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC175 citations99
US8859741B2Oct 14, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC51 citations98
US8829165B2Sep 9, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC76 citations98
US7915391B2Mar 29, 2011
Humanized c-Kit antibody
AMGEN INC112 citations98
US7709611B2May 4, 2010
Antibodies to Dkk-1
AMGEN INC50 citations97
US9056915B2Jun 16, 2015
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC20 citations96
US8981064B2Mar 17, 2015
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC20 citations96
US8889834B2Nov 18, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC25 citations96
US8883983B2Nov 11, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC26 citations96
US8871913B2Oct 28, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC26 citations96
US8871914B2Oct 28, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC26 citations96
US7872106B2Jan 18, 2011
Sclerostin-binding antibodies
AMGEN INC86 citations95
US7868140B2Jan 11, 2011
Human anti-B7RP1 neutralizing antibodies
AMGEN INC33 citations94
US8791249B2Jul 29, 2014
Nucleic acid encoding humanized c-kit antibody
AMGEN INC21 citations92
US7884054B2Feb 8, 2011
Methods for identifying functional antibodies
AMGEN INC37 citations92
US7906625B2Mar 15, 2011
Humanized anti-amyloid antibody
AMGEN INC47 citations89
US9493576B2Nov 15, 2016
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC2 citations73
US10072090B2Sep 11, 2018
Human anti-B7RP1 neutralizing antibodies
AMGEN INC1 citations61
US9266945B2Feb 23, 2016
Human anti-B7RP1 neutralizing antibodies
AMGEN INC1 citations61
US9006408B2Apr 14, 2015
Modified lecithin-cholesterol acyltransferase enzymes
AMGEN INC0 citations48
NGM BIOPHARMACEUTICALS INC
16 patentsUS9920118B2Mar 20, 2018
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC19 citations94
US10562965B2Feb 18, 2020
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC5 citations84
US10174119B2Jan 8, 2019
Binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC10 citations84
US10093735B2Oct 9, 2018
Beta-klotho binding proteins
NGM BIOPHARMACEUTICALS INC4 citations83
US9738716B2Aug 22, 2017
Beta klotho binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC9 citations83
US11530260B2Dec 20, 2022
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC2 citations73
US10975154B2Apr 13, 2021
Binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC2 citations73
US11596676B2Mar 7, 2023
Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereof
NGM BIOPHARMACEUTICALS INC1 citations72
US10995145B2May 4, 2021
Antibodies which bind human glucagon receptor
NGM BIOPHARMACEUTICALS INC2 citations72
US10800843B2Oct 13, 2020
Beta klotho-binding proteins
NGM BIOPHARMACEUTICALS INC3 citations72
US10744191B2Aug 18, 2020
Beta klotho-binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC3 citations72
US12378312B2Aug 5, 2025
Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereof
NGM BIOPHARMACEUTICALS INC0 citations62
US12180289B2Dec 31, 2024
Binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC0 citations62
US12173060B2Dec 24, 2024
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC0 citations62
US11732049B2Aug 22, 2023
Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor
NGM BIOPHARMACEUTICALS INC0 citations62
US11667708B2Jun 6, 2023
Anti-human beta klotho antibody or binding fragment thereof and methods of their use
NGM BIOPHARMACEUTICALS INC1 citations62
JACKSON SIMON MARK
4 patentsUS8563698B2Oct 22, 2013
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK72 citations98
US8168762B2May 1, 2012
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK101 citations98
US9045547B2Jun 2, 2015
Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK42 citations96
US9920134B2Mar 20, 2018
Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK13 citations90